Sectors & IndustriesHealthcareHealthcare Plans

Best Healthcare Plan Stocks to Buy Now (2026)

Top healthcare plan stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best healthcare plan stocks to buy now. Learn More.

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare plan stocks to buy right now are:

Centene (NYSE:CNC) is the #1 top healthcare plan stock out of 10 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Centene (NYSE:CNC) is: Value: B, Growth: B, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: B.

Centene (NYSE:CNC) has a Due Diligence Score of 19, which is -19 points lower than the healthcare plan industry average of 38. Although this number is below the industry average, our proven quant model rates CNC as a "A".

CNC passed 6 out of 33 due diligence checks and has weak fundamentals. Centene has seen its stock return 150.54% over the past year, overperforming other healthcare plan stocks by 117 percentage points.

Centene has an average 1 year price target of $68.35, an upside of 1.31% from Centene's current stock price of $67.47.

Centene stock has a consensus Buy recommendation according to Wall Street analysts. Of the 17 analysts covering Centene, 35.29% have issued a Strong Buy rating, 11.76% have issued a Buy, 52.94% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Oscar Health (NYSE:OSCR) is the #2 top healthcare plan stock out of 10 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Oscar Health (NYSE:OSCR) is: Value: B, Growth: A, Momentum: B, Sentiment: B, Safety: C, Financials: C, and AI: C.

Oscar Health (NYSE:OSCR) has a Due Diligence Score of 50, which is 12 points higher than the healthcare plan industry average of 38.

OSCR passed 17 out of 33 due diligence checks and has strong fundamentals. Oscar Health has seen its stock return 123.16% over the past year, overperforming other healthcare plan stocks by 90 percentage points.

Oscar Health has an average 1 year price target of $25.40, a downside of -22.47% from Oscar Health's current stock price of $32.76.

Oscar Health stock has a consensus Hold recommendation according to Wall Street analysts. Of the 6 analysts covering Oscar Health, 16.67% have issued a Strong Buy rating, 0% have issued a Buy, 83.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Cvs Health (NYSE:CVS) is the #3 top healthcare plan stock out of 10 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Cvs Health (NYSE:CVS) is: Value: C, Growth: B, Momentum: B, Sentiment: B, Safety: B, Financials: C, and AI: B.

Cvs Health (NYSE:CVS) has a Due Diligence Score of 37, which is -1 points lower than the healthcare plan industry average of 38. Although this number is below the industry average, our proven quant model rates CVS as a "A".

CVS passed 13 out of 38 due diligence checks and has average fundamentals. Cvs Health has seen its stock return 45.6% over the past year, overperforming other healthcare plan stocks by 12 percentage points.

Cvs Health has an average 1 year price target of $112.40, an upside of 15.69% from Cvs Health's current stock price of $97.16.

Cvs Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 15 analysts covering Cvs Health, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Out of 5 healthcare plan stocks that have issued dividends in the past year, the 3 healthcare plan stocks with the highest dividend yields are:

Cvs Health (NYSE:CVS) has an annual dividend yield of 2.74%, which is 1 percentage points higher than the healthcare plan industry average of 1.95%. Cvs Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Cvs Health's dividend has shown consistent growth over the last 10 years.

Cvs Health's dividend payout ratio of 69.3% indicates that its dividend yield is sustainable for the long-term.

Unitedhealth Group (NYSE:UNH) has an annual dividend yield of 2.23%, which is the same as the healthcare plan industry average of 1.95%. Unitedhealth Group's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Unitedhealth Group's dividend has shown consistent growth over the last 10 years.

Unitedhealth Group's dividend payout ratio of 57.4% indicates that its dividend yield is sustainable for the long-term.

Cigna Group (NYSE:CI) has an annual dividend yield of 2.17%, which is the same as the healthcare plan industry average of 1.95%. Cigna Group's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Cigna Group's dividend has shown consistent growth over the last 10 years.

Cigna Group's dividend payout ratio of 25.3% indicates that its dividend yield is sustainable for the long-term.

Healthcare plan stocks were up 1.4% in the last day, and up 1.51% over the last week.

We couldn't find a catalyst for why healthcare plan stocks are up.

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare plan stocks right now are:

Cigna Group (NYSE:CI) is the most undervalued healthcare plan stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Cigna Group has a valuation score of 57, which is 38 points higher than the healthcare plan industry average of 19. It passed 4 out of 7 valuation due diligence checks.

Cigna Group's stock has dropped -2.68% in the past year. It has underperformed other stocks in the healthcare plan industry by -36 percentage points.

Elevance Health (NYSE:ELV) is the second most undervalued healthcare plan stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Elevance Health has a valuation score of 29, which is 10 points higher than the healthcare plan industry average of 19. It passed 2 out of 7 valuation due diligence checks.

Elevance Health's stock has gained 35.5% in the past year. It has overperformed other stocks in the healthcare plan industry by 2 percentage points.

Centene (NYSE:CNC) is the third most undervalued healthcare plan stock based on its Valuation Rating of B. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Centene has a valuation score of 14, which is -5 points higher than the healthcare plan industry average of 19. It passed 1 out of 7 valuation due diligence checks. Although this number is below the industry average, our proven quant model rates CNC a Valuation Rating of "B".

Centene's stock has gained 150.54% in the past year. It has overperformed other stocks in the healthcare plan industry by 117 percentage points.

40% of healthcare plan stocks rated by analysts are a buy right now. On average, analysts expect healthcare plan stocks to rise by 8.2% over the next year.

30% of healthcare plan stocks have a Zen Rating of A (Strong Buy), 20% of healthcare plan stocks are rated B (Buy), 50% are rated C (Hold), 0% are rated D (Sell), and 0% are rated F (Strong Sell).